Latest on CP Wire |
“Special Fraud Alert” Targets Pharma & Medical Device Speaker Programs |
Fri, 11/20/20 - 10:48 am |
Launch of Unprecedented Biotech Data Resource |
Thu, 11/12/20 - 10:09 am |
Bigfinite is Now Aizon |
Mon, 10/5/20 - 02:43 pm |
SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise |
Tue, 08/25/20 - 01:22 pm |
Highlights: 2020 Cardiometabolic Health Congress West Live Online |
Fri, 08/21/20 - 12:25 am |
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections |
Mon, 08/3/20 - 09:59 am |
How Contingency Fee Arrangements Empower Whistleblowers |
Wed, 06/24/20 - 10:42 am |
COVID-19 Employment and Whistleblower Issues - Interview With an Employment Attorney |
Wed, 06/3/20 - 11:01 am |
Active Symptom Monitoring Won’t be Effective in Controlling Spread of COVID-19 Once World Returns to “New Normal,” Study Suggests |
Tue, 06/2/20 - 04:48 pm |
Cybersecurity, Pharma, and Whistleblowing |
Fri, 05/15/20 - 03:56 pm |
|
rssfeedwidget.com |